Format

Send to

Choose Destination
JAMA Intern Med. 2019 Jan 22. doi: 10.1001/jamainternmed.2018.8121. [Epub ahead of print]

Physicians' Perspectives on FDA Approval Standards and Off-Label Drug Marketing.

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2
The Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
3
The American Board of Internal Medicine, Philadelphia, Pennsylvania.

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center